Abstract
Idiopathic normal pressure hydrocephalus is a neurological disease caused by abnormal cerebrospinal fluid flow and presents with symptoms such as dementia. Current therapy involves the removal of excess cerebrospinal fluid by shunting. Not all patients respond to this therapy and biomarkers are needed that could facilitate the characterization of patients likely to benefit from this treatment. Here, we measure brain metabolism in normal pressure hydrocephalus patients by performing a novel longitudinal metabolomic profiling study of cerebrospinal fluid. We find that the levels of brain metabolites correlate with clinical parameters, the amount of vascular endothelial growth factor in the cerebrospinal fluid, and environmental stimuli such as exercise. Metabolomic analysis of normal pressure hydrocephalus patients provides insight into changes in brain metabolism that accompany cerebrospinal fluid disorders and may facilitate the development of new biomarkers for this condition.
Graphical Abstract
Similar content being viewed by others
References
Finney GR (2009) Normal pressure hydrocephalus. Int Rev Neurobiol 84:263–281
Meier U, Lemcke J, Al-Zain F (2008) Course of disease in patients with idiopathic normal pressure hydrocephalus (iNPH): a follow-up study 3, 4 and 5 years following shunt implantation. Acta Neurochir Suppl 102:125–127
Brinker T, Stopa E, Morrison J, Klinge P (2014) A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11:10
Wright BL, Lai JT, Sinclair AJ (2012) Cerebrospinal fluid and lumbar puncture: a practical review. J Neurol 259:1530–1545
Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW (2014) Independent information from cerebrospinal fluid amyloid-beta and florbetapir imaging in Alzheimer’s disease. Brain 138:772–783
Palsson E, Jakobsson J, Sodersten K, Fujita Y, Sellgren C, Ekman CJ, Agren H, Hashimoto K, Landen M (2015) Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur Neuropsychopharmacol 25:133–140
Sosvorova L, Vcelak J, Mohapl M, Vitku J, Bicikova M, Hampl R (2014) Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus. Neuro Endocrinol Lett 35:586–593
Pieragostino D, D’Alessandro M, di Ioia M, Rossi C, Zucchelli M, Urbani A, Di Ilio C, Lugaresi A, Sacchetta P, Del Boccio P (2015) An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis. Mol BioSyst 11:1563–1572
Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D (2014) Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS (London, England) 28:1579–1591
Trushina E, Dutta T, Persson XM, Mielke MM, Petersen RC (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer’s disease using metabolomics. PLoS ONE 8:e63644
Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E, Aziat F, Wishart DS (2012) Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4:38
Dombrowski SM, Deshpande A, Dingwall C, Leichliter A, Leibson Z, Luciano MG (2008) Chronic hydrocephalus-induced hypoxia: increased expression of VEGFR-2+ and blood vessel density in hippocampus. Neuroscience 152:346–359
Reeson P, Tennant KA, Gerrow K, Wang J, Weiser Novak S, Thompson K, Lockhart KL, Holmes A, Nahirney PC, Brown CE (2015) Delayed inhibition of VEGF signaling after stroke attenuates blood–brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner. J Neurosci 35:5128–5143
Rosenstein JM, Krum JM, Ruhrberg C (2010) VEGF in the nervous system. Organogenesis 6:107–114
Yang J, Shanahan K, Shriver LP, Luciano M (2015) Exercise-induced respondent changes of CSF vascular endothelial growth factor in adult chronic hydrocephalus patients. J Clin Neurosci 24:52–56
Yang J, Dombrowski SM, Deshpande A, Krajcir N, El-Khoury S, Krishnan C, Luciano MG (2011) Stability analysis of vascular endothelial growth factor in cerebrospinal fluid. Neurochem Res 36:1947–1954
Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID (2006) A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 131:1075–1078
Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440–9445
Koo I, Yao S, Zhang X, Kim S (2014) Comparative analysis of false discovery rate methods in constructing metabolic association networks. J Bioinf Comput Biol 12:1450018
Choi M, Chang CY, Clough T, Broudy D, Killeen T, MacLean B, Vitek O (2014) MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics (Oxford, England) 30:2524–2526
Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA, Jones DP, Pulendran B (2013) Predicting network activity from high throughput metabolomics. PLoS Comput Biol 9:e1003123
Smith CA, O’Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G (2005) METLIN: a metabolite mass spectral database. Ther Drug Monit 27:747–751
Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, Yallou F, Bjorndahl T, Perez-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, Scalbert A (2013) HMDB 3.0–The Human Metabolome Database in 2013. Nucleic Acids Res 41:D801–D807
Petrossian TC, Clarke SG (2011) Uncovering the human methyltransferasome. Mol Cell Proteomics MCP 10(M110):000976
Lu H, Liu X, Deng Y, Qing H (2013) DNA methylation, a hand behind neurodegenerative diseases. Front Aging Neurosci 5:85
Spector R, Robert Snodgrass S, Johanson CE (2015) A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Exp Neurol 273:57–68
Lourenco CF, Ledo A, Dias C, Barbosa RM, Laranjinha J (2015) Neurovascular and neurometabolic derailment in aging and Alzheimer’s disease. Front Aging Neurosci 7:103
Peake JM, Tan SJ, Markworth JF, Broadbent JA, Skinner TL, Cameron-Smith D (2014) Metabolic and hormonal responses to isoenergetic high-intensity interval exercise and continuous moderate-intensity exercise. Am J Physiol Endocrinol Metab 307:E539–E552
Yan B, Jiye A, Wang G, Lu H, Huang X, Liu Y, Zha W, Hao H, Zhang Y, Liu L, Gu S, Huang Q, Zheng Y, Sun J (2009) Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training. J Appl Physiol (Bethesda, Md : 1985) 106:531–538
Brugnara L, Vinaixa M, Murillo S, Samino S, Rodriguez MA, Beltran A, Lerin C, Davison G, Correig X, Novials A (2012) Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. PLoS ONE 7:e40600
Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord EN, Smith AC, Eyassu F, Shirley R, Hu CH, Dare AJ, James AM, Rogatti S, Hartley RC, Eaton S, Costa AS, Brookes PS, Davidson SM, Duchen MR, Saeb-Parsy K, Shattock MJ, Robinson AJ, Work LM, Frezza C, Krieg T, Murphy MP (2014) Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515:431–435
Hamel D, Sanchez M, Duhamel F, Roy O, Honore JC, Noueihed B, Zhou T, Nadeau-Vallee M, Hou X, Lavoie JC, Mitchell G, Mamer OA, Chemtob S (2014) G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery. Arterioscler Thromb Vasc Biol 34:285–293
He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L (2004) Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429:188–193
Li T, Hu J, Du S, Chen Y, Wang S, Wu Q (2014) ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes. Mol Vis 20:1109–1121
Sanchez A, Tripathy D, Luo J, Yin X, Martinez J, Grammas P (2013) Neurovascular unit and the effects of dosage in VEGF toxicity: role for oxidative stress and thrombin. J Alzheimer’s Dis JAD 34:281–291
Shea TB, Rogers E (2014) Lifetime requirement of the methionine cycle for neuronal development and maintenance. Curr Opin Psychiatry 27:138–142
Lam SM, Wang Y, Duan X, Wenk MR, Kalaria RN, Chen CP, Lai MK, Shui G (2014) Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia. Neurobiol Aging 35:2369–2381
Rodrigues GM Jr, Toffoli LV, Manfredo MH, Francis-Oliveira J, Silva AS, Raquel HA, Martins-Pinge MC, Moreira EG, Fernandes KB, Pelosi GG, Gomes MV (2015) Acute stress affects the global DNA methylation profile in rat brain: modulation by physical exercise. Behav Brain Res 279:123–128
Gomez-Pinilla F, Zhuang Y, Feng J, Ying Z, Fan G (2011) Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci 33:383–390
McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D (2008) Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 62(Suppl 2):670–677
Acknowledgments
This work was supported by the University of Akron, Conquer Chiari Foundation, the AB Sciex Young Investigator Award (LPS), and Cleveland Clinic (ML).
Author information
Authors and Affiliations
Corresponding authors
Additional information
He Huang and Jun Yang have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Huang, H., Yang, J., Luciano, M. et al. Longitudinal Metabolite Profiling of Cerebrospinal Fluid in Normal Pressure Hydrocephalus Links Brain Metabolism with Exercise-Induced VEGF Production and Clinical Outcome. Neurochem Res 41, 1713–1722 (2016). https://doi.org/10.1007/s11064-016-1887-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-016-1887-z